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Abstract 
Introduction: Close monitoring of arterial blood pressure (BP) is a central part of cardio-
vascular surveillance of patients at risk for hypotension. Therefore, patients undergoing di-
agnostic and therapeutic procedures with the use of sedating agents are monitored by dis-
continuous non-invasive BP measurement (NIBP). Continuous non-invasive BP monitoring 
based on vascular unloading technique (CNAP®, CN Systems, Graz) may improve patient 
safety in those settings. We investigated if this new technique improved monitoring of pa-
tients undergoing interventional endoscopy.   
Methods: 40 patients undergoing interventional endoscopy between April and December 
2007 were prospectively studied with CNAP® in addition to standard monitoring (NIBP, 
ECG and oxygen saturation). All monitoring values were extracted from the surveillance 
network at one-second intervals, and clinical parameters were documented. The variance of 
CNAP® values were calculated for every interval between two NIBP measurements.   
Results: 2660 minutes of monitoring were recorded (mean 60.1±34.4 min/patient). All pa-
tients were analgosedated with midazolam and pethidine, and 24/40 had propofol infusion 
(mean 90.9±70.3 mg). The mean arterial pressure for CNAP® was 102.4±21.2 mmHg and 
106.8±24.8 mmHg for NIBP. Based on the first NIBP value in an interval between two NIBP 
measurements, BP values determined by CNAP® showed a maximum increase of 
30.8±21.7% and a maximum decrease of 22.4±28.3% (mean of all intervals). 
Discussion: Conventional intermittent blood pressure monitoring of patients receiving se-
dating agents failed to detect fast changes in BP. The new technique CNAP® improved the 
detection of rapid BP changes, and may contribute to a better patient safety for those un-
dergoing interventional procedures. 
Key words: continuous non-invasive blood pressure, procedural sedation, endoscopy, cardiovas-
cular monitoring, hypotension. 
Introduction 
Cardiovascular complications including ar-
rhythmia, ischemia and hypotension during inter-
ventional endoscopy, are not common, but neverthe-
less higher than previously reported, and may cause 
harm to patients [1, 2]. In elderly patients and in those 
with compromised cardiovascular function even short 
episodes of hypotension may cause extensive prob-
lems. Hence close monitoring of the arterial blood 
pressure (BP) is a central part of cardiovascular sur-
veillance in these patients. Theoretically, this is guar-
a n t e e d  a t  b e s t  b y  i n v a s i v e  m o n i t o r i n g  w i t h  a n  i n -




for adverse events like infections or necrosis. There-
fore, patients undergoing diagnostic and therapeutic 
procedures with the use of sedating agents are moni-
tored by discontinuous non-invasive BP measurement 
(NIBP) with measure intervals between 3 to 15 min-
utes as standard. However, hypotensive episodes 
may be missed between these intervals. One possible 
solution may be the application of a new technique of 
continuous non-invasive BP monitoring by CNAP® 
(CN Systems, Graz, Austria) in those settings. 
CNAP® is based on the vascular unloading technique 
and enables a beat-to-beat BP measurement without 
having substantial negative side effects [3, 4]. We 
compared test readings from NIBP and CNAP® val-
ues in patients undergoing interventional endoscopy 
such as endoscopic retrograde cholangiopancrea-
tography (ERCP). The aim of this study was to inves-
tigate the accuracy of NIBP measurements in these 
patients, and if cardiovascular patient monitoring in 
interventional endoscopy could be improved by 
CNAP®.  
Methods 
Study design  
The prospective study took place between April 
and December 2007 on patients undergoing interven-
tional endoscopy. The study was approved by the 
ethics committee of the University of Regensburg and 
performed in accordance with the declaration of Hel-
sinki. 
Patients 
40 patients undergoing interventional endo-
scopy were monitored by CNAP® in addition to 
standard monitoring (NIBP, ECG and oxygen satura-
tion). Patients with peripheral vascular pathology like 
vascular implants and raynaud syndrome were ex-
cluded. All patients were treated with analgosedative 
medication and were asked to limit their arm move-
ments. 
Monitoring values were extracted from the sur-
veillance network at one-second intervals by using 
e-data® software (Draeger medical solutions, Lübeck, 
Germany). Additionally clinical and demographical 
parameters were recorded.  
Materials 
Continuous non-invasive BP monitoring based 
on vascular unloading technique (CNAP®, CN Sys-
tems, Graz, Austria) is commercially available since 
2007. It can be used in combination with Task Force 
Monitor® (CN Systems, Graz, Austria) or with Drae-
ger (Draeger Medical, Lübeck, Germany) and Siemens 
Monitors (Siemens Erlangen, Germany). The method 
is based on concentrical interlocking control loops for 
correct long-term tracing of finger BP, including 
automatic set point adaption, light control and sepa-
rate inlet and outlet valves for electric-pneumatic 
control [3, 4]. The cuff pressure is continuously 
changed through the systolic and diastolic blood 
pressure cycle to keep the finger’s luminescence con-
stant. Therefore, the cuff pressure corresponds to the 
pressure in the finger at any time. CNAP® is cali-
brated by standard NIBP via upper arm’s cuff.   
Figure 1 shows the double-finger cuff, placed at 
patient’s middle and index finger or middle and ring 
finger; respectively. The cuff is connected with the 
cuff controller and the monitoring device.  
 
Figure 1. Interventional endoscopy 
in our gastroenterological depart-
ment; in the left corner the CNAP® 






Data collection and statistical calculations were 
performed using Microsoft Office Access (Version 
2007, Microsoft Corporation, Redmond, USA) and 
SPSS® (SPSS inc, Version 15, Germany). Data are ex-
pressed as mean + SD.  
Results 
Patients 
24 female and 16 male patients, with an average 
age of 59±15 years underwent 32 ERCPs and 8 other 
interventional endoscopies with a mean duration of 
66 minutes ± 34 minutes. Indications leading to en-
doscopy were: malignant stenosis of the hepatic duct 
(n=13), cholelithiasi s  ( n = 8 ) ,  b e n i g n  s t e n o s i s  o f  t h e  
hepatic duct (n=6), pancreati-
tis/pancreas-pseudocysts (n=4), others (n=8). All pa-
tients (mean BMI 25 kg/m²) received midazolam 
(7.4±3.3 mg) and pethidin (52.5±19.2 mg), 24 patients 
were additionally treated with propofol (90.9±70.3 
mg) and 2 patients with ketamine (100.0±50.0 mg). No 
cardiovascular complications following endoscopy 
were detected. 
NIBP and CNAP® values 
2660 minutes of monitoring were recorded. 
Within this time 103 117 CNAP® and 333 NIBP 
measurements were recorded. Furthermore, we rec-
ognized 143 088 heart rate values and 145 665 oxygen 
saturation values. 
The mean NIBP arterial pressure was 
106.82±24.82 mmHg (mean arterial pressure). On av-
erage, 10.3 NIBP measurements were performed per 
endoscopy. The mean arterial pressure values deter-
mined by CNAP® were 102.37±21.20 mmHg and 
therefore not significantly different from the mean 
NIBP values. 
In order to determine blood pressure changes 
undetected by conventional NIBP surveillance, NIBP 
intervals were defined as the time space between two 
adjacent NIBP measurements, and the CNAP read-
ings within these intervals were analyzed (figure 2). In 
total, 254 NIBP intervals were calculated with a mean 
length of 7.5±4.6 minutes.  
 
 
Figure 2.  The variance of 
CNAP® values for every NIBP 
interval based on the first NIBP 
value 




Using standard cardiovascular monitoring, a 
NIBP value is presumed to reflect the patient’s blood 
pressure until a second value is available. Therefore, 
we calculated the variance of CNAP® values for every 
NIBP interval based on the first NIBP value (figure 2). 
With this approach, the maximal increase and de-
crease in blood pressure was calculated for each in-
terval, and the mean of these deviations for all NIBP 
intervals was determined. The mean maximum de-
crease was 27.13±16.81 mmHg (30.85%) and the mean 
maximal increase was 20.69±28.34 mmHg (22.43%) 
per NIPB interval (figure 2).  
Most physicians using NIBP monitoring during 
procedural sedation are conscious of the fact that ar-
terial pressure values may differ between two NIBP 
measurements. We assumed that a fluctuation of 10% 
or 20% of the initial NIBP value can be safely toler-
ated, depending on the initial value (figure 3). In our 
investigation, 45.12% of all mean CNAP® values were 
beyond this “tolerable” interval of 10%, and 15.80% of 
the values were even beyond the 20% range.  
The described deviations of the CNAP blood 
pressure from the first NIBP value might result from a 
c o n t i n u o u s  r i s e  o r  f a l l  t o  t h e  n e x t  m e a s u r e d  N I B P  
value (figure 4). To evaluate if this accounts for the 
deviations described or if there is more fluctuation in 
blood pressure, straight lines between two NIBP val-
ues were calculated and tolerance intervals of ± 10% 
and 20% were set (figure 4). 42.94% of all CNAP® 
values (mean BP) were outside the 10% interval and 
13.38% of the values outside the 20% corridor, dem-
onstrating a profound fluctuation of blood pressure 
values which were not detected by NIBP values. In 
clinical practice, detection of hypotensive episodes is 
more important than the fluctuation of blood pressure 
values. In our data base, none of the systolic blood 
pressure values were lower than 100 mmHg, but with 
CNAP, 3.6% of the registered values were below 100 
mmHg. Therefore, continuous blood pressure sur-
veillance has the potential to detect hypotension ear-




Figure 3. Illustration of the "tolerated" fluctuation of 10% or 20% respectively, based on the initial NIBP value. The per-






Figure 4. Illustration of the "tolerated" fluctuation of 10% or 20% respectively, based on the calculated straight lines be-
tween two NIBP values. The percentage of measurements within this corridor is shown bellow.     
 
Discussion  
Patients undergoing interventional endoscopy, 
as a common example of procedural analgo-sedation, 
require close cardiovascular monitoring due to well 
known complications of sedative agents like hy-
potension and respiratory depression [5]. The use of 
propofol for procedural sedation is increasing because 
of its rapid onset and offset properties [5], although an 
increased rate of fatal complications was published [6] 
and its use in endoscopy is controversially discussed 
by gastroenterologists and anesthesiologists [7, 8]. 
Especially the rate of hypotension measured by the 
method of Riva-Rocci has been reported as high as 
8-12%, although many publications showed the safety 
of propofol for procedural sedation in endoscopy [9, 
10] and in emergency departments [11, 12].   
Our results using a continuous non-invasive BP 
monitoring by vascular unloading technique 
(CNAP®) during interventional endoscopy show that 
there are large BP changes in between the currently 
common discontinuous NIBP measurements, and 
16% of mean CNAP® values differed more than 20% 
from the previous NIBP value. In our study only a few 
episodes of hypotension were detectable, but none of 
these were registered by NIBP measurements. In 
other collectives, the rate of hypotensive episodes 
may be higher. Our data show that the rate of hy-
potension previously determined by NIBP measure-
ments underestimates the true hypotension incidence 
during endoscopy, and especially rapid BP chances 
are often undetected. Unfortunately, the local ethics 
committee did not permit blinding of the CNAP val-




large NIBP intervals, thereby underestimating the 
accuracy of the NIPB measurements. 
The clinical impact of hypotensive episodes dur-
ing procedural sedation is not entirely clear, since 
short hypotensive episodes in general anesthesia are 
rarely been associated with permanent problems [13]. 
However, rapid BP changes may be responsible for 
considerable side effects. Cardio-pulmonary compli-
cations account for the majority of all reported com-
plications during endoscopy [14], [1]. Besides 
well-known serious conditions like respiratory failure 
and cardiac arrest, hypotensive episodes in the car-
diovascular compromised patient may result in 
ischemic complications such as kidney failure or heart 
ischemia [1, 2, 15]. In our study, no serious complica-
tions occurred, but due to the study design the medi-
cal staff was aware of the measured CNAP® blood 
pressure values throughout the study. 
Our study provides evidence that hypo- and 
hypertensive episodes are earlier recognized with a 
continuous noninvasive blood pressure monitoring 
device, and usage of CNAP® may therefore enable 
medical staff to act more rapidly and effectively to BP 
changes before serious adverse events occur. In our 
opinion, this will help to perform procedural sedation 
more safely. 
Conclusion  
Cardiovascular monitoring by CNAP® detects 
rapid changes in blood pressure occurring surpris-
ingly often during procedural sedation and analgesia 
in interventional endoscopy, and may therefore im-
prove patient safety. 
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